SCHEMBL2967040

SCHEMBL2967040

CCCCC1=Cc2cccc(Br)c2C1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.35
GRM2 Q14416 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2972173 0.95 KCNH2 (0.35) TRPA1GRM2
SCHEMBL2965795 0.94 KCNH2 (0.38) TRPA1
SCHEMBL2956645 0.94 KCNH2 (0.38) TRPA1
SCHEMBL2972342 0.94 KCNH2 (0.38) TRPA1
SCHEMBL2962064 0.94 KCNH2 (0.38) TRPA1
SCHEMBL2971504 0.94 KCNH2 (0.38) TRPA1
SCHEMBL2967415 0.90 TRPA1 (0.36) TRPA1
SCHEMBL2971532 0.83 TRPA1 (0.38) TRPA1
SCHEMBL5954196 0.81 DRD3 (0.33)
SCHEMBL27432091 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665774-A1 METALLOCENE CATALYST COMPOUNDS HAVING FERROCENYL SUBSTITUENTS ExxonMobil Technology and Engineering Company (US) 2025-12-24 EP disclosed
WO-2024173956-A1 METALLOCENE CATALYST COMPOUNDS HAVING FERROCENYL SUBSTITUENTS ExxonMobil Technology and Engineering Company (US) 2024-08-22 WO disclosed
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 TRPA1 438/4885GRM2 501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.